98 related articles for article (PubMed ID: 23523713)
1. Reply to: "SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting".
Speletas M; Kioumi A; Germenis AE
J Hepatol; 2013 Aug; 59(2):397. PubMed ID: 23523713
[No Abstract] [Full Text] [Related]
2. SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting.
Wallace DF
J Hepatol; 2013 Aug; 59(2):396-7. PubMed ID: 23523714
[No Abstract] [Full Text] [Related]
3. SLC40A1-R178G mutation and ferroportin disease.
Speletas M; Onoufriadis E; Kioumi A; Germenis AE
J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
[No Abstract] [Full Text] [Related]
4. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
5. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
6. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
[TBL] [Abstract][Full Text] [Related]
7. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
8. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene.
Gordeuk VR; Caleffi A; Corradini E; Ferrara F; Jones RA; Castro O; Onyekwere O; Kittles R; Pignatti E; Montosi G; Garuti C; Gangaidzo IT; Gomo ZA; Moyo VM; Rouault TA; MacPhail P; Pietrangelo A
Blood Cells Mol Dis; 2003; 31(3):299-304. PubMed ID: 14636642
[TBL] [Abstract][Full Text] [Related]
11. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
12. The ferroportin disease.
Pietrangelo A
Blood Cells Mol Dis; 2004; 32(1):131-8. PubMed ID: 14757427
[TBL] [Abstract][Full Text] [Related]
13. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
[TBL] [Abstract][Full Text] [Related]
14. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
15. Ferroportin disease: A novel SLC40A1 mutation.
Ravasi G; Pelucchi S; Russo A; Mariani R; Piperno A
Dig Liver Dis; 2020 Jun; 52(6):688-690. PubMed ID: 32360131
[No Abstract] [Full Text] [Related]
16. [Practical use of genetic markers other than C282Y in iron overload disorders].
Brissot P
Gastroenterol Clin Biol; 2002 Nov; 26(11):991-3. PubMed ID: 12483130
[No Abstract] [Full Text] [Related]
17. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
18. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.
Politou M; Kalotychou V; Pissia M; Rombos Y; Sakellaropoulos N; Papanikolaou G
Haematologica; 2004 Apr; 89(4):490-2. PubMed ID: 15075083
[TBL] [Abstract][Full Text] [Related]
19. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.
Beutler E; Barton JC; Felitti VJ; Gelbart T; West C; Lee PL; Waalen J; Vulpe C
Blood Cells Mol Dis; 2003; 31(3):305-9. PubMed ID: 14636643
[TBL] [Abstract][Full Text] [Related]
20. Gene symbol: SLC40A1. Disease: Primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2005 May; 116(6):541. PubMed ID: 15991323
[No Abstract] [Full Text] [Related]
[Next] [New Search]